STOCK TITAN

Insider sale: AvePoint (AVPT) CLO trades 10,000 shares via 10b5-1

(Moderate)
(Negative)
Form Type
4

Rhea-AI Filing Summary

AvePoint, Inc. director and Chief Legal Officer Brown Brian Michael reported selling 10,000 shares of common stock in two open-market transactions on July 28–29, 2026, at prices of $13.06 and $13.08 per share. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted on December 16, 2025. Footnotes explain that reported equity holdings, when shown, combine non-RSU common shares with vested and unvested RSUs subject to previously disclosed vesting schedules.

Positive

  • None.

Negative

  • None.
Insider Brown Brian Michael
Role Chief Legal Officer
Sold 10,000 shs ($131K)
Type Security Shares Price Value
Sale Common Stock F1, F2 5,176 $13.06 $68K
Sale Common Stock F1, F2 4,824 $13.08 $63K
Holdings After Transaction: Common Stock — 809,664 shares (Direct)
Footnotes (2)
  1. F1. The sale transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025.
  2. F2. Includes non-RSU common stock as well as aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I of Form 4s filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022, March 23, 2023, March 7, 2024, March 18, 2025, and March 18, 2026.
Shares sold on 2026-07-29 5,176 shares Common stock sale at $13.06 per share
Shares sold on 2026-07-28 4,824 shares Common stock sale at $13.08 per share
Total shares sold 10,000 shares Aggregate common stock sold across both reported transactions
Sale price 2026-07-29 $13.06 per share Per-share price for 5,176-share common stock sale
Sale price 2026-07-28 $13.08 per share Per-share price for 4,824-share common stock sale
Rule 10b5-1 trading plan regulatory
"The sale transaction was effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
RSUs financial
"Includes non-RSU common stock as well as aggregate vested and unvested RSUs held"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
vesting schedules financial
"RSUs held by the Reporting Person subject to the vesting schedules previously reported"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider stock sales did AvePoint (AVPT) report in this Form 4?

AvePoint disclosed that Brown Brian Michael sold 10,000 shares of common stock on July 28–29, 2026 in open-market transactions at $13.06 and $13.08 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

Who is the insider involved in the AvePoint (AVPT) Form 4 transaction?

The transactions involve Brown Brian Michael, a director and Chief Legal Officer of AvePoint, Inc. He is the reporting person for the sale of 10,000 shares of AvePoint common stock disclosed in the Form 4 filing.

Were the AvePoint (AVPT) stock sales made under a Rule 10b5-1 trading plan?

Yes. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Brown Brian Michael on December 16, 2025, indicating the trades were pre-arranged rather than discretionary at the time of execution.

What type of securities did Brown Brian Michael sell in AvePoint (AVPT)?

He sold common stock of AvePoint, Inc. Footnote disclosure indicates that reported equity holdings, when presented, aggregate non-RSU common shares with both vested and unvested RSUs subject to previously disclosed vesting schedules.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Brown Brian Michael

(Last)(First)(Middle)
C/O AVEPOINT, INC.
901 E BYRD ST, SUITE 900

(Street)
RICHMOND VIRGINIA 23219

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AvePoint, Inc. [ AVPT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Legal Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/28/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/28/2026S4,824(1)D$13.08814,840(2)D
Common Stock07/29/2026S5,176(1)D$13.06809,664(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sale transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025.
2. Includes non-RSU common stock as well as aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I of Form 4s filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022, March 23, 2023, March 7, 2024, March 18, 2025, and March 18, 2026.
/s/ Brian Michael Brown07/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)